NCT04567264View on ClinicalTrials.gov

Wireless, Implantable Tibial Nerve Stimulator System for the Treatment of Refractory Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DEVICE

StimRouter®, Self-activated and self-controlled neuromodulation device (Bioness Inc, CE0086).

"Regimen 1 (weeks 0-12): one stimulation every 2 days, for a duration of 30 minutes each.~Regimen 2 (weeks 12-24): Three stimulation treatments per week, for a duration of 30 minutes each."

Trial Locations (1)

6903

Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland, Lugano

All Listed Sponsors
collaborator

ABREOC

UNKNOWN

lead

Chiara Zecca

OTHER

NCT04567264 - Wireless, Implantable Tibial Nerve Stimulator System for the Treatment of Refractory Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter